TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 92 filers reported holding TRICIDA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,118,000 | -19.1% | 870,000 | -25.3% | 2.20% | -18.8% |
| Q2 2022 | $11,275,000 | +9.7% | 1,164,763 | -6.8% | 2.70% | +8.9% |
| Q1 2022 | $10,275,000 | -23.2% | 1,250,000 | -10.7% | 2.48% | -16.5% |
| Q4 2021 | $13,384,000 | +46.1% | 1,400,000 | -29.1% | 2.97% | +39.4% |
| Q3 2021 | $9,159,000 | +7.4% | 1,974,000 | 0.0% | 2.13% | +19.2% |
| Q2 2021 | $8,528,000 | +361.2% | 1,974,000 | +464.6% | 1.79% | +368.3% |
| Q1 2021 | $1,849,000 | -89.8% | 349,600 | -40.4% | 0.38% | -77.0% |
| Q3 2019 | $18,118,000 | -100.0% | 586,929 | -58.8% | 1.66% | -73.3% |
| Q2 2019 | $56,191,000,000 | – | 1,423,998 | – | 6.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |